Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125408941 | 12540894 | 1 | I | 20160627 | 20160708 | 20160708 | PER | US-ELI_LILLY_AND_COMPANY-US201606009952 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160708 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125408941 | 12540894 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Unknown | UNK, UNKNOWN | U | U | 20592 | TABLET | |||||||
| 125408941 | 12540894 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | 10 MG, TID | U | U | 20592 | 10 | MG | TABLET | TID | ||||
| 125408941 | 12540894 | 3 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 100 MG, AT BEDTIME | U | 0 | 100 | MG | QD | ||||||
| 125408941 | 12540894 | 4 | C | BENZATROPINE | BENZTROPINE | 1 | Unknown | 0.5 MG, AT BEDTIME | U | 0 | .5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125408941 | 12540894 | 1 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125408941 | 12540894 | Hallucination, auditory | |
| 125408941 | 12540894 | Prescribed overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |